Theratechnologies (TH.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
(Values in thousands)
| 05-2025 | 02-2025 | 11-2024 | 08-2024 | 05-2024 | |
| Sales | 17,729 | 19,047 | 25,002 | 22,600 | 22,017 |
| Cost of Goods | 4,699 | 3,483 | 6,096 | 4,521 | 4,547 |
| Gross Profit | 13,030 | 15,564 | 18,906 | 18,079 | 17,470 |
| Operating Expenses | 14,934 | 13,669 | 17,987 | 11,866 | 14,182 |
| Operating Income | -1,904 | 1,895 | 919 | 6,213 | 3,288 |
| Interest Expense | 1,107 | 1,125 | 2,415 | 2,661 | 2,695 |
| Other Income | -1,205 | -346 | -5,386 | 295 | 512 |
| Pre-tax Income | -4,216 | 424 | -6,882 | 3,847 | 1,105 |
| Income Tax | 246 | 307 | 1,021 | 756 | 118 |
| Net Income Continuous | -4,462 | 117 | -7,903 | 3,091 | 987 |
| Net Income | $-4,462 | $117 | $-7,903 | $3,091 | $987 |
| EPS Basic Total Ops | -0.09 | 0.00 | -0.16 | 0.06 | 0.02 |
| EPS Basic Continuous Ops | -0.09 | 0.00 | -0.16 | 0.06 | 0.02 |
| EPS Diluted Total Ops | -0.09 | 0.00 | -0.16 | 0.06 | 0.02 |
| EPS Diluted Continuous Ops | -0.09 | 0.00 | -0.16 | 0.06 | 0.02 |
| EBITDA(a) | $-2,636 | $2,040 | $-3,974 | $6,997 | $5,062 |